Image of Controversies in Thyroidology: Clinical Application of Molecular Testi
On Demand

Controversies in Thyroidology: Clinical Application of Molecular Testing in the Treatment of Advanced and Metastatic Thyroid Carcinoma


Duration:
2 Hours
Format:
Audio and Video


Description

 

Our first of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office. 


Program Details

This course includes a live Q&A session with faculty. Join the May 29, 2020 1:00 PM ET broadcast to be a part of the live Q&A session or post May 29 watch on-demand and receive credit for up to one year from the date of webinar release. Registrants will be notified as new webinars in the series are released. 2.0 credits available until August 31, 2021. View the Accreditation Statement/Credit tab for details.

 

Controversies in Thyroidology: Clinical Application of Molecular Testing in the Treatment of Advanced and Metastatic Thyroid Carcinoma

Moderator: Whitney S. Goldner

Differentiated Thyroid Carcinoma (Naifa L. Busaidy, MD)

     Learning Objectives: TBD

Medullary Thyroid Carcinoma (Mimi Hu, MD)

     Learning Objectives:

  • Understand the pathogenic abnormalities associated with medullary thyroid cancer
  • Describe the agents available for advanced medullary thyroid cancer (MTC)
  • Explore how mutational profile and extent of disease may influence treatment plan
  • NOTE: This presentation will not review the natural history or the evaluation and workup of MTC

Influence of Molecular Testing on Surgical Approach (Mark E. Zafereo, MD)

    Learning Objectives:

  • Indications and current evidence for integration of neoadjuvant targeted therapy with surgery for:
    • Anaplastic thyroid cancer
    • Advanced differentiated thyroid cancer
    • Medullary thyroid cancer

Learn more...

Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/


Who Should Attend

American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).

Credits

Accreditation Statement/Credit

Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Colorado School of Medicine designates this other activity (combination of live and enduring activities) for a maximum of 2.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC).  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

 




Faculty

Naifa L. Busaidy's Profile

Naifa L. Busaidy Related seminars and products: 2


Naifa Busaidy, MD  is a Tenured Associate Professor in the Department of Endocrine Neoplasia & Hormonal Disorders at the University of Texas – MD Anderson Cancer Center.  Her clinical expertise and research interests are primarily focus driven to treat and improve outcomes in patients with aggressive thyroid carcinomas. Dr Busaidy went to Baylor College of Medicine for medical school and her internal medicine residency. She completed her Endocrine fellowship at the combined program of Baylor College of Medicine and the University of Texas - MD Anderson Cancer Center. Her additional research fellowship year at MD Anderson advanced her clinical and research knowledge in Endocrine Tumors. She joined the faculty at UT MD Anderson Cancer Center in 2004 and climbed the ranks to Tenured Associate Professor.  She serves on several institutional committees. There, she also directs the thyroid nodule clinic where they see patients with the spectrum of the disease from initial visit to diagnosis on the same day with results.  As an oncologic endocrinologist, she serves as Principal Investigator and Co-Investigator of both National Cancer Institute sponsored and industry sponsored trials and publishes on several clinical trials identifying the molecular mechanisms of disease progression and identify targets for improving response to therapy. She serves on the National Comprehensive Cancer Network (NCCN) Thyroid Cancer Guidelines Committee.  She has served as the Endocrine expert on the National Cancer Institute’s PI3K/mTOR taskforce.  As well as advisory boards and as a consultant for oncology groups and industry to shape the treatment spectrum of thyroid cancer today.  Dr. Busaidy’s service to the American Thyroid Association includes the program committee, research grant committee and the awards committee. She is a member of the International Thyroid Oncology Group Board, AACE, Endocrine Society and several societies where she enjoys serving on multiple committees including mentorship and research committees.  She is a fellow of the American Association of Clinical Endocrinologists. She has published extensively on Endocrine tumors, specifically thyroid cancer and Endocrine effects of cancer therapy.


Mimi Hu's Profile

Mimi Hu Related seminars and products: 2


Mimi Hu, MD graduated from Rice University with a degree in mechanical engineering. She obtained her medical degree from the University of Texas - Houston Health Sciences Center. She completed her residency and endocrine fellowship at Baylor College of Medicine, where she also served as chief medical resident. After completion of her research fellowship at MD Anderson, she joined the faculty in 2007 in the department of Endocrine Neoplasia and Hormonal Disorders. Dr. Hu's clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma (differentiated and medullary), hereditary endocrine neoplasia disorders and metabolic bone and mineral disorders. She is the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders. She is the director of the Oncologic Endocrine Fellowship program at MD Anderson, the first-of-its-kind training program to provide specialized education in the care and management of patients with endocrine neoplasias/cancers or endocrine complications from cancer or its treatments.


Mark E. Zafereo's Profile

Mark E. Zafereo Related seminars and products: 2


Mark E. Zafereo, Jr., MD is an Associate Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas. He is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Endocrine Center at MD Anderson Cancer Center. Dr. Zafereo holds national committee appointments for the American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, and American Board of Otolaryngology-Head and Neck Surgery, and he is a Past President of the Houston Society of Otolaryngology-Head and Neck Surgery. He has published extensively on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.

 


Whitney S. Goldner's Profile

Whitney S. Goldner Related seminars and products: 3


Whitney Goldner, MD is an Endocrinologist at the University of Nebraska Medical Center, Omaha, NE. She is an Associate Professor of Medicine in the Division of Diabetes, Endocrinology, and Metabolism, Dept of Internal Medicine. She is the PI of ICaRe2, which is a bioinformatics registry and biospecimen bank at UNMC for thyroid nodules and thyroid cancer. She specializes in thyroid disease, thyroid nodules, and thyroid cancer as well as neuroendocrine tumors and other Endocrine disorders. She is the Endocrinology Fellowship Program director and runs the thyroid ultrasound and biopsy clinics.


Kepal Patel's Profile

Kepal Patel Related seminars and products: 5


Kepal N. Patel, MD is the Chief of the Division of Endocrine Surgery and an Associate Professor of Surgery, Otolaryngology and Biochemistry at NYU Langone Medical Center. He is the Director of the Thyroid Interdisciplinary Program and has particular expertise in the multidisciplinary treatment of Thyroid and Parathyroid disease along with other head and neck tumors. He also leads the translational research program for the Division of Endocrine Surgery. Dr. Patel has been studying the molecular pathogenesis of thyroid carcinoma by focusing on the changes in intracellular pathways that lead to the progression of thyroid cancer. His research interests also include studying the relationship of autoimmune thyroiditis to thyroid cancer at the genomic level.
He earned his M.D. from UMDNJ-Robert Wood Johnson Medical School and completed his Oncologic Head and Neck Surgery training at Memorial Sloan-Kettering Cancer Center. Dr. Patel’s work has been recognized by numerous awards from prestigious societies such as the American Society of Clinical Oncology, American Head and Neck Society, American Association of Endocrine Surgeons, and the American Thyroid Association. He currently serves in multiple leadership roles both locally and nationally and is a reviewer and on the editorial board of several journals.


Accreditation Statement/Credit

Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Colorado School of Medicine designates this other activity (combination of live and enduring activities) for a maximum of 2.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC).  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

 

Please wait ...

Back to Top